TOMSICEK MICHAEL JOHN

CIK 00015703925 companiesWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001570392

Recent Transactions

50 trades

Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2026-06-17+20,275→ 20,275 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2026-06-10+77,000→ 77,000 total
Award
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2026-05-18+9,366→ 9,366 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2025-06-13+20,275→ 20,275 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2025-06-10+40,000→ 40,000 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2024-08-28+40,000→ 40,000 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2024-06-20+20,275→ 20,275 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2023-06-07+30,000→ 30,000 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2022-11-14+35,235→ 35,235 total
Purchase
Milestone Pharmaceuticals Inc.$MIST
Common Shares
2022-10-19$5.32/sh+15,000→ 15,000 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2022-07-05+30,000→ 30,000 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-08-06$139.46/sh−5,989→ 1,891 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-08-06$138.22/sh−19,011→ 7,880 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2021-08-06$17.75/sh+25,000→ 26,891 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2021-06-14+30,000→ 30,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-03-11−25,000→ 131,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-03-11+25,360→ 25,360 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2021-03-11+9,000→ 9,000 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-10$124.15/sh−1,352→ 1,891 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-10+2,833→ 3,243 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-10-05+11,666→ 11,666 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-09-01$91.39/sh−2,800→ 9,610 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-09-01$92.23/sh−6,400→ 3,210 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2020-09-01$17.75/sh+12,000→ 12,410 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-09-01−12,000→ 156,000 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-09-01$93.18/sh−2,800→ 410 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2020-08-03$17.75/sh+12,000→ 12,410 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-08-03$86.25/sh−6,552→ 5,858 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-08-03$87.33/sh−5,448→ 410 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2020-06-05+15,000→ 15,000 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2020-03-10+8,500→ 8,500 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-03-10+35,000→ 35,000 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2019-12-03+20,000→ 20,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2019-03-05+75,000→ 75,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2018-06-15+20,760→ 20,760 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2018-03-07+25,000→ 25,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2017-11-13+180,000→ 180,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2017-11-13−12,000→ 168,000 total
Tax Payment
ABIOMED INC
Common Stock, $.01 par value
2017-07-15$145.07/sh−3,925→ 27,081 total
Tax Payment
ABIOMED INC
Common Stock, $.01 par value
2017-05-24$134.74/sh−1,567→ 34,931 total
Award
ABIOMED INC
Common Stock, $.01 par value
2017-05-15+8,198→ 34,998 total
Award
ABIOMED INC
Stock option (right to buy)
2017-05-15+6,000→ 6,000 total
Award
ABIOMED INC
Common Stock, $.01 par value
2017-05-15+1,500→ 36,498 total
Award
ABIOMED INC
Stock option (right to buy)
2016-05-24+5,000→ 5,000 total
Award
ABIOMED INC
Common Stock, $.01 par value
2016-05-24+1,800→ 26,800 total
Award
ABIOMED INC
Stock option (right to buy)
2015-07-15+25,000→ 25,000 total
Award
ABIOMED INC
Common Stock, $.01 par value
2015-07-15+25,000→ 25,000 total
Award
ABIOMED INC
Stock option (right to buy)
2015-07-15+25,000→ 25,000 total
Disposition to Issuer
CUBIST PHARMACEUTICALS INC
Performance Restricted Stock Units
2015-01-21−3,004→ 0 total
Disposition to Issuer
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2015-01-21−31,559→ 0 total

Companies

Recent Filings

Address

C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100

WATERTOWN, MA, 02472

View on SEC.gov